Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03997513 · ClinicalTrials.gov registry record · NA
The Impact of a Home-based Pulmonary Telerehabilitation Program in Acute Exacerbations of COPD
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03997513: Completed NA study, sponsored by VA Office of Research and Development.
NCT03997513 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03997513, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
COPD impacts a significant proportion of the Veteran population. Acute exacerbations, or flare-ups, of COPD are associated with impaired muscle function and worse quality of life. Pulmonary rehabilitation, a formal exercise program for patients with lung disease that includes both endurance and strength training exercises, has been shown to improve muscle function and quality of life after an acute exacerbation of COPD. However, lack of geographically accessible rehabilitation facilities and/or transportation issues are often barriers to pulmonary rehabilitation attendance in the Veteran population. This study will assess the feasibility and impact of an eight-week, three sessions per week, home-based, pulmonary telerehabilitation program in Veterans with COPD following hospitalization for an acute exacerbation of their lung disease. We will measure adherence and satisfaction with the program and muscle strength, physical activity, quality of life, and exercise tolerance pre and post-intervention in Veterans randomized to the pulmonary telerehabilitation arm versus Veterans randomized to the control arm who do not participate in pulmonary rehabilitation.
Interventions
- BEHAVIORAL Pulmonary Telerehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2022-06-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03997513
The ClinicalTrials.gov registry entry for NCT03997513 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary Telerehabilitation is the first listed.
NCT03997513 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03997513 about?
NCT03997513 is a clinical study titled "The Impact of a Home-based Pulmonary Telerehabilitation Program in Acute Exacerbations of COPD". COPD impacts a significant proportion of the Veteran population. Acute exacerbations, or flare-ups, of COPD are associated with impaired muscle function and worse quality of life. Pulmonary rehabilitation, a formal exercise program for patients with lung disease that includes both endurance and stre...
What is the current status of trial NCT03997513?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2020-09-01. Estimated completion is 2022-06-28.
What interventions are being tested in trial NCT03997513?
The interventions under investigation include: Pulmonary Telerehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03997513?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.